Washington University, St. Louis
St Louis, Missouri, 63130, United States
Location status: Recruiting
NCT Number: NCT07397559
Spinal cord injury leads to long-lasting impairment, and currently, there is no cure for paralysis. Although transcutaneous spinal cord stimulation has shown promising results in recovering lost movements, its poor selectivity in muscle recruitment compared to invasive approaches limits the type of rehabilitation exercises that can be practiced. This project studies how spatial, frequency, and amplitude control of stimulation can be used to selectively target different neural pathways and muscle groups.
Interested in participating?
Request Info16 year–65 year
All sexes
Interventional
Not applicable
St Louis, Missouri, 63130, United States
Location status: Recruiting
Spinal cord injury (SCI) is a life-altering event that leads to long-lasting motor impairment. Currently, there is no cure for paralysis. Transcutaneous spinal cord stimulation (tSCS) combined with exercise training can restore posture control, voluntary walking, and arm/hand function in people with SCI. However, its low selectivity in activating specific muscles compared to invasive approaches limits the rehabilitation exercises that can be practiced and help with recovery. This project will generate evidence-based knowledge of the neural mechanisms underlying spatial, frequency, and amplitude control of tSCS in generating different types of leg movements. Participants with SCI will perform leg movements using different stimulation parameter configurations in non-invasive tSCS. We will quantify changes in muscle recruitment, torque generation, and pain enabled by the different stimulation parameters. A clear understanding of the mechanisms by which these different parameters in non-invasive tSCS can be used to selectively target different muscle groups will promote the development of personalized therapies that directly target only those muscles that need assistance while respecting individuals' residual motor function.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants complete motor tasks and outcome assessments with no spinal cord stimulation applied.
Non-invasive transcutaneous spinal cord stimulation (tSCS) is delivered at 30 Hz using a single cathode electrode targeting the lumbar spinal cord to reinforce leg motor output during study tasks
Stimulation parameters, including electrode location, stimulation frequency, and stimulation amplitude, are systematically varied to reinforce leg motor output during study tasks
Time frame: 30 minutes
The primary outcome is a measure of changes in voluntary torque production (Nm)
Time frame: 30 minutes
Muscle activation will be measured through electromyography as the peak-to-peak of the evoked responses (mV)
Time frame: 30 minutes
Pain will be evaluated using the Nociception Level (NOL) index during the different stimulation conditions. (Range: 0-100, 0 = no detectable nociceptive response, 100 = extreme nociceptive response)
Contact information is provided by the study sponsor or research team.
Carolyn Atkinson, BS
CONTACT
Ismael Seáñez, PhD
CONTACT
Washington University School of Medicine
Other
Spatiotemporal Control of Transcutaneous Spinal Cord Stimulation for Motor Function in SCI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07699094
Blood Pressure, Central Nervous System Diseases
The Bronx, New York, United States
View Trial DetailsNCT07692191
Back Injuries, Behavior
Winnipeg, Manitoba, Canada
View Trial DetailsNCT07521930
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Baltimore, Maryland, United States
View Trial DetailsNCT06841198
Autonomic Nervous System Diseases, Basal Ganglia Diseases
West Orange, New Jersey, United States
View Trial Details